📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Validation of the protein kinase PfCLK3 as a multistage cross-species malarial drug target. (2019)

First Author: Alam MM

Attributed to: Bitopic protein kinase inhibition - a new paradigm in drug discovery funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/science.aau1682

PubMed Identifier: 31467193

Publication URI: http://europepmc.org/abstract/MED/31467193

Type: Journal Article/Review

Volume: 365

Parent Publication: Science (New York, N.Y.)

Issue: 6456

ISSN: 0036-8075